Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Diagnosis of Human Immunodeficiency Virus Infection.

Parekh BS, Ou CY, Fonjungo PN, Kalou MB, Rottinghaus E, Puren A, Alexander H, Hurlston Cox M, Nkengasong JN.

Clin Microbiol Rev. 2018 Nov 28;32(1). pii: e00064-18. doi: 10.1128/CMR.00064-18. Print 2019 Jan. Review.

PMID:
30487166
2.
3.

Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa.

Grebe E, Welte A, Johnson LF, van Cutsem G, Puren A, Ellman T, Etard JF; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA), Huerga H.

PLoS One. 2018 Sep 13;13(9):e0203638. doi: 10.1371/journal.pone.0203638. eCollection 2018.

4.

Community-based HIV prevalence in KwaZulu-Natal, South Africa: results of a cross-sectional household survey.

Kharsany ABM, Cawood C, Khanyile D, Lewis L, Grobler A, Puren A, Govender K, George G, Beckett S, Samsunder N, Madurai S, Toledo C, Chipeta Z, Glenshaw M, Hersey S, Abdool Karim Q.

Lancet HIV. 2018 Aug;5(8):e427-e437. doi: 10.1016/S2352-3018(18)30104-8. Epub 2018 Jul 17.

PMID:
30021700
5.

Beyond Social Desirability Bias: Investigating Inconsistencies in Self-Reported HIV Testing and Treatment Behaviors Among HIV-Positive Adults in North West Province, South Africa.

Mooney AC, Campbell CK, Ratlhagana MJ, Grignon JS, Mazibuko S, Agnew E, Gilmore H, Barnhart S, Puren A, Shade SB, Liegler T, Lippman SA.

AIDS Behav. 2018 Jul;22(7):2368-2379. doi: 10.1007/s10461-018-2155-9.

PMID:
29779162
6.

South African HIV self-testing policy and guidance considerations.

Venter F, Majam M, Jankelowitz L, Adams S, Moorhouse M, Carmona S, Stevens W, Msimanga BR, Allen D, Balani P, Nevhutalu Z, Rhagnath N, Shroufi A, Devillé W, Kazangarare V, van der Wiel R, Templeman H, Puren A, Tucker T, van Cutsem G, Conradie F, Dong K, Chidarikire T, Gray A.

South Afr J HIV Med. 2017 Sep 22;18(1):775. doi: 10.4102/sajhivmed.v18i1.775. eCollection 2017.

7.

Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.

Huerga H, Van Cutsem G, Ben Farhat J, Puren A, Bouhenia M, Wiesner L, Dlamini L, Maman D, Ellman T, Etard JF.

BMC Public Health. 2018 Mar 2;18(1):303. doi: 10.1186/s12889-018-5208-0.

8.

Adolescent Access to Care and Risk of Early Mother-to-Child HIV Transmission.

Ramraj T, Jackson D, Dinh TH, Olorunju S, Lombard C, Sherman G, Puren A, Ramokolo V, Noveve N, Singh Y, Magasana V, Bhardwaj S, Cheyip M, Mogashoa M, Pillay Y, Goga AE.

J Adolesc Health. 2018 Apr;62(4):434-443. doi: 10.1016/j.jadohealth.2017.10.007. Epub 2017 Dec 19.

9.

Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing.

Kufa T, Kharsany AB, Cawood C, Khanyile D, Lewis L, Grobler A, Chipeta Z, Bere A, Glenshaw M, Puren A.

J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21753. doi: 10.7448/IAS.20.7.21753.

10.

Progress of UNAIDS 90-90-90 targets in a district in KwaZulu-Natal, South Africa, with high HIV burden, in the HIPSS study: a household-based complex multilevel community survey.

Grobler A, Cawood C, Khanyile D, Puren A, Kharsany ABM.

Lancet HIV. 2017 Nov;4(11):e505-e513. doi: 10.1016/S2352-3018(17)30122-4. Epub 2017 Aug 2.

PMID:
28779855
11.

The accuracy of HIV rapid testing in integrated bio-behavioral surveys of men who have sex with men across 5 Provinces in South Africa.

Kufa T, Lane T, Manyuchi A, Singh B, Isdahl Z, Osmand T, Grasso M, Struthers H, McIntyre J, Chipeta Z, Puren A.

Medicine (Baltimore). 2017 Jul;96(28):e7391. doi: 10.1097/MD.0000000000007391.

12.

Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.

Gentle NL, Loubser S, Paximadis M, Puren A, Tiemessen CT.

Hum Immunol. 2017 Jul - Aug;78(7-8):503-509. doi: 10.1016/j.humimm.2017.05.006. Epub 2017 May 29.

PMID:
28571758
13.

Toward elimination of mother-to-child transmission of HIV in South Africa: how best to monitor early infant infections within the Prevention of Mother-to-Child Transmission Program.

Sherman GG, Mazanderani AH, Barron P, Bhardwaj S, Niit R, Okobi M, Puren A, Jackson DJ, Goga AE.

J Glob Health. 2017 Jun;7(1):010701. doi: 10.7189/jogh.07.010701.

14.

Women's knowledge and perception of male circumcision before and after its roll-out in the South African township of Orange Farm from community-based cross-sectional surveys.

Maraux B, Lissouba P, Rain-Taljaard R, Taljaard D, Bouscaillou J, Lewis D, Puren A, Auvert B.

PLoS One. 2017 Mar 24;12(3):e0173595. doi: 10.1371/journal.pone.0173595. eCollection 2017.

15.

An association between decreasing incidence of invasive non-typhoidal salmonellosis and increased use of antiretroviral therapy, Gauteng Province, South Africa, 2003-2013.

Keddy KH, Takuva S, Musekiwa A, Puren AJ, Sooka A, Karstaedt A, Klugman KP, Angulo FJ.

PLoS One. 2017 Mar 6;12(3):e0173091. doi: 10.1371/journal.pone.0173091. eCollection 2017.

16.

Obtaining a male circumcision prevalence rate of 80% among adults in a short time: An observational prospective intervention study in the Orange Farm township of South Africa.

Marshall E, Rain-Taljaard R, Tsepe M, Monkwe C, Taljaard D, Hlatswayo F, Xaba D, Molomo T, Lissouba P, Puren A, Auvert B.

Medicine (Baltimore). 2017 Jan;96(4):e5328. doi: 10.1097/MD.0000000000005328.

17.

The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets.

Takuva S, Brown AE, Pillay Y, Delpech V, Puren AJ.

AIDS. 2017 Feb 20;31(4):545-552. doi: 10.1097/QAD.0000000000001340.

PMID:
28121668
18.

Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study.

de Oliveira T, Kharsany AB, Gräf T, Cawood C, Khanyile D, Grobler A, Puren A, Madurai S, Baxter C, Karim QA, Karim SS.

Lancet HIV. 2017 Jan;4(1):e41-e50. doi: 10.1016/S2352-3018(16)30186-2. Epub 2016 Dec 1.

19.

Hepatitis C genotype distribution in patient and blood donor samples in South Africa for the period 2008-2012.

Prabdial-Sing N, Chirwa T, Thaver J, Smuts H, Vermeulen M, Suchard M, Puren AJ.

J Viral Hepat. 2016 Nov;23(11):881-888. doi: 10.1111/jvh.12571. Epub 2016 Aug 21.

PMID:
27545625
20.

Population-level effectiveness of PMTCT Option A on early mother-to-child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT.

Goga AE, Dinh TH, Jackson DJ, Lombard CJ, Puren A, Sherman G, Ramokolo V, Woldesenbet S, Doherty T, Noveve N, Magasana V, Singh Y, Ramraj T, Bhardwaj S, Pillay Y; South Africa PMTCT Evaluation (SAPMCTE) Team.

J Glob Health. 2016 Dec;6(2):020405.

21.

Sequential Cross-Sectional Surveys in Orange Farm, a Township of South Africa, Revealed a Constant Low Voluntary Medical Male Circumcision Uptake among Adults despite Demand Creation Campaigns and High Acceptability.

Marshall E, Rain-Taljaard R, Tsepe M, Monkwe C, Hlatswayo F, Tshabalala S, Khela S, Xulu L, Xaba D, Molomo T, Malinga T, Puren A, Auvert B.

PLoS One. 2016 Jul 18;11(7):e0158675. doi: 10.1371/journal.pone.0158675. eCollection 2016.

22.

Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012.

Jean K, Puren A, Cutler E, Singh B, Bouscaillou J, Rain-Taljaard R, Taljaard D, Gouws E, Lissouba P, Lewis DA, Peytavin G, Auvert B.

AIDS. 2016 Aug 24;30(13):2107-16. doi: 10.1097/QAD.0000000000001155.

PMID:
27163707
23.

Attrition and Opportunities Along the HIV Care Continuum: Findings From a Population-Based Sample, North West Province, South Africa.

Lippman SA, Shade SB, El Ayadi AM, Gilvydis JM, Grignon JS, Liegler T, Morris J, Naidoo E, Prach LM, Puren A, Barnhart S.

J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):91-9. doi: 10.1097/QAI.0000000000001026.

24.

Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa.

Prabdial-Sing N, Blackard JT, Puren AJ, Mahomed A, Abuelhassan W, Mahlangu J, Vermeulen M, Bowyer SM.

Antiviral Res. 2016 Mar;127:90-8. doi: 10.1016/j.antiviral.2015.11.011. Epub 2015 Dec 17.

PMID:
26704023
25.

Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa.

Kharsany AB, Cawood C, Khanyile D, Grobler A, Mckinnon LR, Samsunder N, Frohlich JA, Abdool Karim Q, Puren A, Welte A, George G, Govender K, Toledo C, Chipeta Z, Zembe L, Glenshaw MT, Madurai L, Deyde VM, Bere A.

BMC Public Health. 2015 Nov 20;15:1149. doi: 10.1186/s12889-015-2179-2.

26.

A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods.

Rehle T, Johnson L, Hallett T, Mahy M, Kim A, Odido H, Onoya D, Jooste S, Shisana O, Puren A, Parekh B, Stover J.

PLoS One. 2015 Jul 31;10(7):e0133255. doi: 10.1371/journal.pone.0133255. eCollection 2015.

27.

Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE).

Woldesenbet S, Jackson D, Lombard C, Dinh TH, Puren A, Sherman G, Ramokolo V, Doherty T, Mogashoa M, Bhardwaj S, Chopra M, Shaffer N, Pillay Y, Goga A; South African PMTCT Evaluation (SAPMCTE) Team.

PLoS One. 2015 Jul 6;10(7):e0132425. doi: 10.1371/journal.pone.0132425. eCollection 2015.

28.

Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.

Kuhn L, Schramm DB, Shiau S, Strehlau R, Pinillos F, Technau K, Coovadia A, Abrams EJ, Puren A, Tiemessen CT.

AIDS. 2015 Jun 1;29(9):1053-60. doi: 10.1097/QAD.0000000000000677.

29.

Design and implementation of an external quality assessment program for HIV viral load measurements using dried blood spots.

Prach LM, Puren A, Lippman SA, Carmona S, Stephenson S, Cutler E, Barnhart S, Liegler T.

J Clin Microbiol. 2015 Mar;53(3):964-6. doi: 10.1128/JCM.02698-14. Epub 2014 Dec 17.

30.

Exploring HIV infection and susceptibility to measles among older children and adults in Malawi: a facility-based study.

Polonsky JA, Singh B, Masiku C, Langendorf C, Kagoli M, Hurtado N, Berthelot M, Heinzelmann A, Puren A, Grais RF.

Int J Infect Dis. 2015 Feb;31:61-7. doi: 10.1016/j.ijid.2014.12.010. Epub 2014 Dec 12.

31.

First population-level effectiveness evaluation of a national programme to prevent HIV transmission from mother to child, South Africa.

Goga AE, Dinh TH, Jackson DJ, Lombard C, Delaney KP, Puren A, Sherman G, Woldesenbet S, Ramokolo V, Crowley S, Doherty T, Chopra M, Shaffer N, Pillay Y; South Africa PMTCT Evaluation Team.

J Epidemiol Community Health. 2015 Mar;69(3):240-8. doi: 10.1136/jech-2014-204535. Epub 2014 Nov 4.

32.

Frequencies of immune hypersensitivity reaction-associated HLA class I alleles in healthy South African Indian and mixed ancestry populations determined by a novel real-time PCR assay.

Loubser S, Paximadis M, Gentle N, Puren A, Gray CM, Tiemessen CT.

Tissue Antigens. 2014 Oct;84(4):389-97. doi: 10.1111/tan.12414. Epub 2014 Aug 25.

PMID:
25154892
33.

Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011.

Gumede N, Lentsoane O, Burns CC, Pallansch M, de Gourville E, Yogolelo R, Muyembe-Tamfum JJ, Puren A, Schoub BD, Venter M.

Emerg Infect Dis. 2013 Oct;19(10):1583-9. doi: 10.3201/eid1910.130028.

34.

Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys.

Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J, Peytavin G, Mahiane SG, Sitta R, Puren A, Lewis D.

PLoS Med. 2013;10(9):e1001509. doi: 10.1371/journal.pmed.1001509. Epub 2013 Sep 3.

35.

[The Mobile Precarity Team: a tool for building relations].

Crambert G, Puren A, Bougon A, Quellennec P.

Soins Psychiatr. 2013 Jul-Aug;(287):25-8. French.

PMID:
23951740
36.

Genetic variability in markers of HLA-C expression in two diverse South African populations.

Gentle NL, Paximadis M, Puren A, Tiemessen CT.

PLoS One. 2013 Jul 5;8(7):e67780. doi: 10.1371/journal.pone.0067780. Print 2013.

37.

Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa.

Sartorius B, Cohen C, Chirwa T, Ntshoe G, Puren A, Hofman K.

Bull World Health Organ. 2013 Mar 1;91(3):174-83. doi: 10.2471/BLT.12.110726. Epub 2013 Jan 11.

38.

Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009-2011.

Ntshoe GM, McAnerney JM, Archer BN, Smit SB, Harris BN, Tempia S, Mashele M, Singh B, Thomas J, Cengimbo A, Blumberg LH, Puren A, Moyes J, van den Heever J, Schoub BD, Cohen C.

PLoS One. 2013;8(2):e55682. doi: 10.1371/journal.pone.0055682. Epub 2013 Feb 20.

40.

Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010.

Pretorius MA, Madhi SA, Cohen C, Naidoo D, Groome M, Moyes J, Buys A, Walaza S, Dawood H, Chhagan M, Haffjee S, Kahn K, Puren A, Venter M.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S159-65. doi: 10.1093/infdis/jis538.

PMID:
23169964
41.

Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa.

Metcalf CJ, Cohen C, Lessler J, McAnerney JM, Ntshoe GM, Puren A, Klepac P, Tatem A, Grenfell BT, Bjørnstad ON.

J R Soc Interface. 2013 Jan 6;10(78):20120756. doi: 10.1098/rsif.2012.0756.

42.

The World Health Organization African region external quality assessment scheme for anti-HIV serology.

Cham F, Maleka M, Masango M, Goetsch E, Belabbes EH, Singh B, Gershy-Damet GM, Puren A.

Afr J Lab Med. 2012 Nov 7;1(1):39. doi: 10.4102/ajlm.v1i1.39. eCollection 2012.

43.

Evaluation of blood collection filter papers for HIV-1 DNA PCR.

Masciotra S, Khamadi S, Bilé E, Puren A, Fonjungo P, Nguyen S, Girma M, Downing R, Ramos A, Subbarao S, Ellenberger D.

J Clin Virol. 2012 Oct;55(2):101-6. doi: 10.1016/j.jcv.2012.06.010. Epub 2012 Jul 7.

PMID:
22776163
44.

Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009.

Hunt GM, Ledwaba J, Basson AE, Moyes J, Cohen C, Singh B, Bertagnolio S, Jordan MR, Puren A, Morris L.

Clin Infect Dis. 2012 May;54 Suppl 4:S334-8. doi: 10.1093/cid/cir1017.

45.

Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population.

Paximadis M, Mathebula TY, Gentle NL, Vardas E, Colvin M, Gray CM, Tiemessen CT, Puren A.

Hum Immunol. 2012 Jan;73(1):80-92. doi: 10.1016/j.humimm.2011.10.013. Epub 2011 Oct 23.

PMID:
22074999
46.

Adult male circumcision as an intervention against HIV: an operational study of uptake in a South African community (ANRS 12126).

Lissouba P, Taljaard D, Rech D, Dermaux-Msimang V, Legeai C, Lewis D, Singh B, Puren A, Auvert B.

BMC Infect Dis. 2011 Sep 26;11:253. doi: 10.1186/1471-2334-11-253.

47.

Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the Southern Hemisphere: Argentina, Australia, Chile, New Zealand and South Africa.

Van Kerkhove MD, Mounts AW, Mall S, Vandemaele KA, Chamberland M, dos Santos T, Fitzner J, Widdowson MA, Michalove J, Bresee J, Olsen SJ, Quick L, Baumeister E, Carlino LO, Savy V, Uez O, Owen R, Ghani F, Paterson B, Forde A, Fasce R, Torres G, Andrade W, Bustos P, Mora J, Gonzalez C, Olea A, Sotomayor V, Najera De Ferrari M, Burgos A, Hunt D, Huang QS, Jennings LC, Macfarlane M, Lopez LD, McArthur C, Cohen C, Archer B, Blumberg L, Cengimbo A, Makunga C, McAnerney J, Msimang V, Naidoo D, Puren A, Schoub B, Thomas J, Venter M; WHO Southern Hemisphere Influenza Comparison Study Working Group.

Influenza Other Respir Viruses. 2011 Nov;5(6):e487-98. doi: 10.1111/j.1750-2659.2011.00249.x. Epub 2011 Apr 20. Review.

48.

Palindromic-nucleotide substitutions (PNS) of hepatitis C virus genotypes 1 and 5a from South Africa.

Prabdial-Sing N, Giangaspero M, Puren AJ, Mahlangu J, Barrow P, Bowyer SM.

J Virol Methods. 2011 Aug;175(2):272-7. doi: 10.1016/j.jviromet.2011.05.005. Epub 2011 May 10.

PMID:
21600241
49.

Association of low-risk human papillomavirus infection with male circumcision in young men: results from a longitudinal study conducted in Orange Farm (South Africa).

Tarnaud C, Lissouba P, Cutler E, Puren A, Taljaard D, Auvert B.

Infect Dis Obstet Gynecol. 2011;2011:567408. doi: 10.1155/2011/567408. Epub 2011 Apr 7.

50.

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath MJ, Robertson M, Corey L, Kublin JG; HVTN 503/Phambili study team.

Lancet Infect Dis. 2011 Jul;11(7):507-15. doi: 10.1016/S1473-3099(11)70098-6. Epub 2011 May 11. Erratum in: Lancet Infect Dis. 2011 Jul;11(7):495.

Supplemental Content

Support Center